Global EditionASIA 中文双语Français
China
Home / China / International spotlight

Chinese COVID-19 vaccine 'shows no serious side effects' in Turkey

CGTN | Updated: 2020-12-03 14:02
Share
Share - WeChat
A volunteer is injected with an experimental Chinese coronavirus disease (COVID-19) vaccine as Turkey began final Phase III trials at Kocaeli University Research Hospital in Kocaeli, Turkey, Sept 25, 2020. [Photo/Agencies]

Volunteers given a Chinese COVID-19 vaccine candidate in clinical trials have reported no major side effects, local media Hurriyet Daily News reported Monday, citing Turkish officials.

The phase-3 trials of the Chinese COVID-19 vaccine in Turkey started on September 15 on health workers and volunteers at higher risk of infection at 25 centers across 12 provinces.

The participants were given two doses of the vaccine, with the second shot given on the 14th day of the first. They were monitored regularly for 28 days after the second shot and the side effects were recorded on a daily basis. Later on, the plan is to call them every week for a year to keep a check on their health.

So far, they have reported no significant side effects, and some of the most common side effects include tiredness, headache, muscle pain and fever, the report said.

Turkey has ordered COVID-19 vaccines from China

Turkish Health Minister Fahrettin Koca previously announced that the country had signed a contract to buy 50 million doses of the COVID-19 vaccine from China's Sinovac Biotech.

According to him, at least 10 million doses of the vaccine will be delivered in December, but the target is to get about 20 million doses. Another 20 million doses are scheduled for January 2021, and at least 10 million doses will be delivered in February. He said Turkey had also been in talks with other vaccine developers from Russia and the US.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US